EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer

Zhiyan Zhan, Jiarong Zhang, Huisheng Liang, Chong Wang, Li Hong, Wenxue Liu iD

Advanced Science · 2024

DOI: 10.1002/advs.202400140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhiyan Zhan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Poly (ADP-Ribose) Polymerase-1. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most clinical PARP inhibitors (PARPis) trap PARP1 in a chromatin‐bound state, leading to PARPi‐mediated cytotoxicity. PARPi resistance impedes the treatment of ovarian cancer in clinical practice. However, the mechanism by which cancer cells overcome PARP1 trapping to develop PARPi resistance remains unclear. Here, it is shown that high levels of KAT6A promote PARPi resistance in ovarian cancer, regardless of its catalytic activity. Mechanistically, the liquid‐liquid phase separation (LLPS) of KAT6A, facilitated by APEX1, inhibits the cytotoxic effects of PARP1 trapping during PARPi treatment. The stable KAT6A‐PARP1‐APEX1 complex reduces the amount of PARP1 trapped at the DNA break sites. In addition, inhibition of KAT6A LLPS, rather than its catalytic activity, impairs DNA damage repair and restores PARPi sensitivity in ovarian cancer both in vivo and in vitro. In conclusion, the findings demonstrate the role of KAT6A LLPS in fostering PARPi resistance and suggest that repressing KAT6A LLPS can be a potential therapeutic strategy for PARPi‐resistant ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsPoly (ADP-Ribose) Polymerase-1FemaleHumansMiceCell Line, TumorAnimalsHistone AcetyltransferasesDisease Models, AnimalDrug Resistance, Neoplasm

Stichwörter der Autor:innen

APEX1KAT6APARP1 trappingliquid‐liquid phase separationovarian cancer

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly (ADP-Ribose) Polymerase-1PARP1 protein, humanHistone Acetyltransferases

Autor:innen und Institutionen

  • Department of Clinical Nutrition, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Clinical Research Center, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Gynecology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, 361000, China.
  • Department of Obstetrics and Gynecology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, 85 Wujin Road, Shanghai, 200080, China.

ORCID-Profile: Wenxue Liu

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Fujian Provincial Health Technology Project
  • Key Subject Program for Clinical Nutrition from Shanghai Municipal Health Commission
  • Zhongshan Development Program
  • Research fund of Zhongshan Hospital
  • National Key Research and Development Program of China

Zitieren

APA

Zhan, Z., Zhang, J., Liang, H., Wang, C., Hong, L., & Liu, W. (2024). KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer. Advanced Science. https://doi.org/10.1002/advs.202400140

Vancouver

Zhan Z, Zhang J, Liang H, Wang C, Hong L, Liu W. KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer. Advanced Science. 2024. doi:10.1002/advs.202400140

BibTeX
@article{Zhan2024,
  author = {Zhan, Zhiyan and Zhang, Jiarong and Liang, Huisheng and Wang, Chong and Hong, Li and Liu, Wenxue},
  title = {KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202400140}
}
Kostenlos starten →